In the highly regulated and technically demanding world of biopharma, pharmaceuticals, and specialty chemicals, process validation is a critical milestone in bringing a product to market. It ensures that a process is not only effective and reproducible but also compliant with strict regulatory standards. Traditionally, achieving this level of confidence has required significant time, resources, and expertise, relying on carefully designed experiments, statistical analysis, and deep technical knowledge.
While these methods have successfully guided countless products to market, even the most rigorous experiments can leave questions unanswered. Lab-scale trials may not fully reflect commercial-scale performance, subtle fluid or thermal behaviours can remain hidden, and unexpected process deviations can introduce uncertainty.Understanding the Bottlenecks: The Challenges of Biopharma Process Optimization.
Rather than replacing established experimental approaches, digital models and digital twins act as powerful allies. A digital twin is a virtual replica of a physical process, enabling real-time monitoring, predictive simulation, and exploration of complex process behaviours. By integrating digital models with your experimental workflows, you can:
Traditional experiments and human expertise remain essential for process validation. Digital modelling doesn’t replace this foundation—it amplifies it, providing new insights, accelerating decision-making, and improving predictability. By combining experimental rigor with virtual simulation, organizations can achieve a more complete, confident, and efficient path to process validation.
While digital models offer significant advantages, implementing them in process validation can present certain challenges.
One common challenge is data integration. Gathering and standardizing data from various sources can be complex and time-consuming. Ensuring that the data is clean and accurate is crucial for creating reliable simulations.
Another challenge is validating the digital models themselves. It is essential to ensure that the models accurately represent the physical system, which may require initial physical trials for comparison.
SimSight from Tridiagonal Software is designed to combine the full potential of digital twins, CFD, and AI& ML to redefine process validation. Here’s how it makes a difference:
Traditional approaches limit you to testing a handful of operating conditions due to time and cost constraints. With SimSight, you can explore the entire design space virtually. Sensitivity analysis highlights the parameters that matter most-whether it’s agitation speed, addition strategy, or temperature ramp rates-so you can zero in on robust operating windows without the guesswork.
When performance deviates from expectations, SimSight allows you to “look inside” the process. Instead of speculating, you can visualize:
● Dead zones where mixing is poor which may impact on the yield/conversion, byproduct formation.
Scaling from lab to pilot to commercial scale is one of the riskiest stages in product development. SimSight simulates scaling effects-predicting how flow, heat transfer, or mass transport will change with equipment size. This reduces the need for repeated intermediate trials and helps you transition confidently to full production with fewer surprises.
With virtual prototyping, you can test process designs under a wide range of operating conditions, disturbances, and edge cases. This builds robustness into the process before it ever runs at scale, ensuring more consistent product quality and reducing variability.
Agencies increasingly expect a science- and risk-based approach to validation. SimSight provides clear, mechanistic evidence of process understanding that complements experimental data. This strengthens your regulatory submissions and accelerates approvals.
Consider a protein formulation process where dilution must be carefully controlled to avoid aggregation. Using SimSight, engineers can:
● Identify optimal mixing speeds to minimize shear damage.
● Determine the best point of addition for proteins to ensure uniform dispersion.
● Predict outcomes across multiple scales, avoiding costly trial-and-error.
The result? Improved consistency, reduced protein loss, and measurable cost savings per batch. Instead of waiting for problems to surface during production, risks are identified and mitigated proactively in the digital environment.
The shift from empirical to digital validation represents more than just a technological advancementit’s a mindset shift. Instead of reacting to deviations after they occur, companies can - and prevent them. Instead of relying on partial visibility, they can understand processes holistically.
This proactive, knowledge-based approach offers several strategic advantages:
● Faster time-to-market for new drugs and products.
● Lower development costs by reducing physical trials.
● Greater process confidence during scale-up and commercial production.
● Enhanced compliance with a clear demonstration of process understanding.
Process validation has always been about ensuring reliability and reproducibility. But the tools we use to achieve that goal are evolving. With SimSight and digital twin technology, organizations no longer need to depend on trial-and-error or partial insights. Instead, they can validate processes with confidence, armed with data-driven foresight and mechanistic clarity.